European Union Trademark No. 002305654 (Word) Trademark register: EUIPO Status: registration expired

Word mark

The European Union Trademark for DISCERNA (Word) was filed on 05.07.2001 for goods and services in class(es) 5, 10 and 42 at the European Union Intellectual Property Office (EUIPO). The current status of the trademark No. 002305654 DISCERNA is 'registration expired'.

Trademark information
RegisterEuropean Union Intellectual Property Office (EUIPO)
Filing date05.07.2001
Registration date13.12.2002
Expiry date05.07.2011
Nice classes5, 10 and 42
OwnerDiscerna Limited
 CB2 4AT Babraham,, Cambridge, GB
RepresentativeKILBURN & STRODE LLP
 WC1R 4PJ London, GB
Goods and Services (the trademark is registered for the following goods and services)
Class 5 : Antibody based therapy and prophylaxis products, pharmaceutical and biochemical substances and preparations, vaccines, reagents for medical research applications and medical diagnosis, antibodies, immunoglobins, immunoconjugates, protein conjugates, antibody conjugates and cell-lines secreting antibodies and fusion proteins, radioactive and detectably labelled preparations and substances for medical and veterinary use, diagnostic and analytical preparations for medical and veterinary use, diagnostic products for medical purposes; pharmaceutical and biochemical preparations for the treatment of cancer, osteoarthritis, rheumatoid arthritis and degenerative muscular disorders.... More
Class 10 : Instruments and apparatus for the administration of antibody-based therapy and prophylaxis preparations and substances, syringes and injectors for medical purposes.
Class 42 : Biotechnology services, scientific and medical research and development, contract research services, medical services, licensing of intellectual property, high throughput screening services, advisory services relating to diagnostic products.
tmdb is a free trademark search website of publicly available records. tmdb does not guarantee nor warrant the accuracy, completeness or timeliness of the data.